Peizeng Yang Selected Research

Vitamin D

1/2021	Higher 25-hydroxyvitamin D level is associated with increased risk for Behçet's disease.
2/2014	Polymorphisms in genetics of vitamin D metabolism confer susceptibility to ocular Behçet disease in a Chinese Han population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peizeng Yang Research Topics

Disease

56	Uveitis 10/2022 - 03/2002
49	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 01/2021 - 04/2002
41	Behcet Syndrome (Behcet's Syndrome) 04/2022 - 04/2002
24	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 05/2007
21	Inflammation (Inflammations) 03/2021 - 04/2002
14	Anterior Uveitis 04/2021 - 01/2013
9	Ankylosing Spondylitis 01/2021 - 01/2013
7	Hypersensitivity (Allergy) 01/2012 - 06/2006
6	Cataract (Cataracts) 06/2020 - 01/2011
5	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 01/2013
4	Necrosis 01/2020 - 05/2003
3	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 03/2002
3	Glaucoma 01/2022 - 03/2002
3	Retinal Vasculitis 03/2021 - 01/2013
2	Infections 01/2022 - 01/2020
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2020 - 01/2013
1	Papilledema 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Multifocal Choroiditis 01/2022
1	Hepatitis B 01/2022
1	Hepatitis 01/2022
1	Atrophy 01/2022
1	Choroidal Neovascularization 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Congenital Abnormalities (Deformity) 01/2022
1	Blau syndrome 01/2022
1	Exanthema (Rash) 01/2022
1	Epiretinal Membrane (Epiretinal Membranes) 01/2022
1	Tuberculosis (Tuberculoses) 04/2021

Drug/Important Bio-Agent (IBA)

17	Interleukin-17 (Interleukin 17)IBA 01/2021 - 05/2007
10	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 04/2002
8	Messenger RNA (mRNA)IBA 01/2021 - 03/2007
7	Retinaldehyde (Retinal)IBA 01/2022 - 03/2002
7	CytokinesIBA 01/2021 - 05/2010
7	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2007
7	AntigensIBA 01/2018 - 03/2002
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2021 - 05/2009
5	MicroRNAs (MicroRNA)IBA 01/2021 - 08/2012
5	LigandsIBA 01/2020 - 01/2011
5	InterleukinsIBA 01/2015 - 10/2010
4	Fluorescein (Funduscein)FDA LinkGeneric 01/2022 - 04/2002
4	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2016
4	Interleukin-23 (Interleukin 23)IBA 01/2021 - 05/2007
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
4	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2015 - 07/2009
3	Prednisone (Sone)FDA LinkGeneric 01/2022 - 04/2002
3	Monocyte Chemoattractant ProteinsIBA 01/2020 - 08/2009
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2016
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018 - 07/2008
3	HLA Antigens (Human Leukocyte Antigens)IBA 03/2016 - 01/2008
3	Interleukin-10 (Interleukin 10)IBA 01/2015 - 01/2014
3	OvalbuminIBA 07/2008 - 06/2006
2	Long Noncoding RNAIBA 04/2022 - 11/2019
2	NucleotidesIBA 01/2022 - 12/2013
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022 - 04/2002
2	Biological ProductsIBA 01/2021 - 09/2015
2	IGF-I-IGFBP-3 complex FDA Link 01/2021 - 01/2020
2	Vitamin D FDA LinkGeneric 01/2021 - 02/2014
2	Peptides (Polypeptides)IBA 07/2020 - 07/2009
2	BerberineIBA 04/2020 - 04/2013
2	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2020 - 09/2014
2	InterferonsIBA 01/2020 - 01/2019
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2018 - 01/2014
2	Interleukin-4 (Interleukin 4)IBA 09/2017 - 01/2017
2	Carrier Proteins (Binding Protein)IBA 09/2017 - 04/2016
2	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 08/2017 - 01/2017
2	C-Type Lectins (C-Type Lectin)IBA 01/2017 - 03/2015
2	ChemokinesIBA 01/2017 - 07/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016 - 07/2009
2	Interleukin-1 (Interleukin 1)IBA 10/2016 - 07/2009
2	Complement System Proteins (Complement)IBA 08/2015 - 01/2015
2	P-2 (P 2)IBA 03/2015 - 02/2014
2	Complement C4 (Complement Component 4)IBA 01/2015 - 11/2013
2	Interleukin-27 (Interleukin 27)IBA 05/2014 - 07/2012
2	TNF Receptor-Associated Factor 5IBA 01/2014 - 01/2013
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2013 - 01/2012
2	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 05/2009 - 01/2008
2	HLA-DR53IBA 05/2009 - 01/2008
2	Fc Receptors (Fc Receptor)IBA 05/2009 - 01/2008
2	Interleukin-23 Subunit p19IBA 07/2008 - 05/2007
2	EndotoxinsIBA 03/2007 - 05/2003
1	Air Pollutants (Pollutants, Air)IBA 10/2022
1	antineoplaston A10 (A 10)IBA 10/2022
1	Succinic Acid (Succinate)IBA 03/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2022
1	ChromatinIBA 01/2022
1	HLA-A*26 antigenIBA 01/2022
1	LipidsIBA 01/2022
1	ProgranulinsIBA 01/2022
1	Ranibizumab (Lucentis)FDA Link 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	LuciferasesIBA 01/2022
1	Fluocinolone Acetonide (Capex)FDA LinkGeneric 01/2022

Therapy/Procedure

9	Therapeutics 01/2022 - 07/2008
3	Transplantation 01/2021 - 01/2018
3	Phacoemulsification 06/2020 - 08/2012